What Mayo, Fountain Life and Galleri actually charge, what is inside the package, and which parts your own doctor can do for free.
This in-depth guide covers everything you need to know about longevity clinic and executive physical cost in 2026. Based on verified income data and real-world case studies from our database of 138 side hustle tactics.
At Fountain Life, a longevity clinic, testing alone costs $10,500 and a full membership costs $21,500 a year, according to TechCrunch's August 2025 report, while a hospital executive physical cost between $1,700 and $10,000 in a 2019 JAMA survey of top-ranked hospitals. The most useful parts of either package are the evidence-based screenings your regular doctor can already order, often at no cost to you. The flashier extras, such as the $949 Galleri cancer blood test and $499 biological age tests, are interesting and still unproven as ways to help you live longer.
What the rich actually buy when they "get everything checked"
Picture a chief executive flying into Rochester, Minnesota on a Monday. By Tuesday afternoon she has seen an internist, walked a treadmill with electrodes on her chest, had blood drawn, sat for a hearing test and, if she is 50 or older, had a colonoscopy. She flies home Wednesday with a written plan.
That is the classic executive physical. The newer version is the longevity clinic, where you pay an annual membership for whole-body imaging, large blood panels, genetic tests and an app that tracks your numbers between visits.
Both promise that nothing is hiding. Which one would you pick if money were no object? And which one would you pick if you had to justify the bill to yourself?
Executive physicals: Mayo Clinic, Cleveland Clinic and the hospital model
Mayo Clinic Executive Health
Mayo is the name most people know. Its Executive Health FAQ says each visit typically takes two days, occasionally one or three, and that most patients return every year. The program is selective: Mayo's program managers "review business title, company information, work status, and other criteria" before inviting applicants, and appointment calendars open three months ahead.
Mayo does not publish a price. The same FAQ says cost "can vary executive-to-executive and appointment-to-appointment" because each visit is personalised by age, sex, history and the optional services you add. Mayo says it will share cost estimates for its standard protocol if you apply. Two details stand out:
- Mayo says "the majority of a visit is typically covered by insurance," though not everything is.
- It has "well over 1,200 corporate clients" who pay for executives as a work benefit.
So many people in that waiting room have an employer paying.
What do they get? Mayo's standard protocol page lists, for a first visit at age 50 and older: a physical exam, lab work, cardiovascular counseling, a resting ECG, a chest X-ray, an exercise treadmill ECG, an audiogram, PSA for men, breast and cervical screening for women, a bone density scan for women 50 and up and men 65 and up, an abdominal aortic ultrasound for men 65 to 75, and a colonoscopy. Mayo's program pages now also offer genetic testing and multi-cancer early detection testing as optional add-ons.
Mayo's costs page adds that extra testing, "including colonoscopies and biopsies, may be ordered by the physician as clinically indicated" and can change both the length of your stay and the bill. It also charges a cancellation fee if you cancel or reschedule within 30 days of the exam.
Cleveland Clinic Executive Health
Cleveland Clinic's executive health exam page says every appointment includes "a thorough physical exam, nutrition consultation, exercise counseling," a vaccination review and executive coaching. Tests are tailored to you and can include blood work, an EKG, a cardiac stress test, a calcium-score heart scan, spirometry, a chest X-ray or CT, vascular screening and a bone density test. It notes that extra consultations "may require an extra day or two." No price is listed.
What a top hospital charges, and what the study found inside the box
The best public price data comes from researchers at Memorial Sloan Kettering. In a 2019 research letter in JAMA, Deborah Korenstein, Maha Mamoor and Peter Bach looked at 50 top-ranked US hospitals. Of those, 32 sold executive physical packages. Details were available for 29, which offered 46 packages costing from $1,700 to $10,000.
Then they checked the contents against the US Preventive Services Task Force, the independent panel that grades screening tests by evidence. Here is what they found:
- "Low-dose computed tomographic screening for lung cancer (grade A) was not included in any package." The Task Force's current 2021 recommendation grades it B for people aged 50 to 80 who have smoked at least 20 pack-years, which still means it is recommended.
- Resting ECGs were offered by 83% of the hospitals and exercise stress tests by 62%, though the Task Force recommends against both in low-risk adults.
- Carotid ultrasound, which the Task Force also recommends against for screening, was offered by 35%.
- Hearing tests, eye exams and coronary calcium scores appeared often, even though the Task Force says the evidence is insufficient to recommend them for everyone.
The expensive package often included tests with weak support and sometimes skipped one with strong support. Does that change how you read a two-day itinerary full of scans?
In fairness, Mayo's FAQ says its protocol is built on Task Force guidelines plus its own best-practice recommendations, and it reviews the protocol every year. The real value people describe is time, an unhurried doctor, fast specialist referrals and one place that holds the whole picture.
Longevity clinics: Fountain Life and the membership model
Fountain Life
Fountain Life is run by CEO William Kapp, with entrepreneur Peter Diamandis and coach Tony Robbins as co-founders and board members, according to TechCrunch. TechCrunch reported in August 2025:
- "A full subscription costs $21,500 a year, which covers a barrage of tests" plus access to a physician, without extended medical care.
- "For $10,500, a patient can get just the testing process and AI, but not ongoing tests and medical support."
- Testing repeats roughly every quarter across more than 100 biomarkers, and members follow their results in an app called Zori.
Kapp admitted to the outlet that it is "pricey," and said the first principle of longevity is "don't die of anything stupid." It is also the cheapest part of the idea to copy.
Fountain Life's own site lists four memberships: CORE, APEX, Executive Health and APEX Family. It does not post prices, mentions "whole-body MRI & advanced imaging," and says the initial assessment is completed in a single day. It lists centers in Dallas, Orlando, Naples, New York and Houston, with Miami and Los Angeles marked as coming soon. As of 2026 it asks you to request a consultation for a quote.
Human Longevity
Human Longevity is one of the few that publishes a number. Its 100+ Concierge page lists a "$19,000 annual membership." Extras on top of its base tier include a continuous glucose monitor, a Zio heart-rhythm patch, Cologuard, a "GRAIL Cancer Liquid Biopsy Blood Test" and an MRI body composition scan, plus concierge primary care on weekdays from 9am to 5pm.
Notice that last item. Part of what a longevity clinic sells is a primary care doctor who answers quickly. If that is the piece you want, our concierge medicine cost post prices that piece by itself.
What is in a typical package
Most packages are built from the same blocks:
- Large blood panels. Lipids, glucose markers, hormones, inflammation. Consumer services now sell these directly; the Function Health review covers that model.
- Whole-body MRI. The signature longevity clinic scan. Its benefits and false-alarm problem get a full treatment in the post on whether Prenuvo is worth it.
- Heart imaging. Calcium scores or coronary CT angiography.
- Body composition. DEXA or MRI-based fat and muscle measures.
- Genetics. Sometimes whole genome sequencing.
- A multi-cancer blood test. Usually Galleri.
- A biological age test. Usually an epigenetic clock.
The last two are where the newest money goes.
Galleri: the $949 multi-cancer blood test
What it is and what it costs
Galleri, made by GRAIL, looks for a cancer "signal" in DNA fragments in a blood sample and then predicts the likely site of that cancer, as King's College London describes it. HealthDay reported in February 2026 that "The test costs $949 and is not federally approved." As of October 2026 that is still true: Galleri's own site says the test "has not been cleared or approved by the Food and Drug Administration," and that it is recommended for adults at elevated cancer risk, "such as those age 50 or older." The company also warns that "False positive (a cancer signal detected when cancer is not present) and false negative (a cancer signal not detected when cancer is present) test results do occur."
Would you want to know about a cancer signal if the follow-up scans could not find anything? That is a real scenario with this test, and it is worth deciding in advance how you would handle it.
What the NHS-Galleri trial showed
The big test of the idea was the NHS-Galleri trial in England, the first large randomised trial of a multi-cancer blood test. King's College London reports that more than 142,000 volunteers aged 50 to 77 gave three blood samples over two years, and that full results were presented at the ASCO cancer conference on 30 May 2026.
The headline result was a miss. In the university's words: "There was no difference in the number of people diagnosed with late-stage cancer overall (stage 3 and stage 4 cancers together), the main goal of the trial, between people who had the test and those who did not."
The secondary results were more encouraging. GRAIL's results release reports:
- Stage IV diagnoses across the 12 prespecified cancers fell 14% overall, with 9%, 22% and 26% reductions in rounds one, two and three. The company calls the overall figure nominally significant.
- Cancers diagnosed after an emergency presentation, such as arriving at A&E, fell 25%.
- Stage I and II diagnoses of those cancers rose 16%.
- The positive predictive value was 52%: roughly half of people told they had a cancer signal turned out to have cancer.
- Specificity was 99.55%, a false positive rate of 0.45%.
What the trial cannot tell you yet is whether anyone lived longer. GRAIL says only that "Follow-up will continue, with further results published as available." Finding a cancer earlier only helps if earlier treatment changes the outcome, and that question is still open.
Where approval stands
On 23 September 2026 an FDA advisory panel voted on Galleri. CancerNetwork reports the panel voted 10 to 0 on safety, 6 to 4 in favour on effectiveness, and 7 to 2 with one abstention that benefits outweigh risks. In a separate study, PATHFINDER 2, the test caught 39.3% of all cancers diagnosed within 12 months. GRAIL's release on the vote notes that the FDA "is not bound by the Committee's recommendations" and says a final decision is expected "in the coming months."
A 39% catch rate means a clear result is reassuring only up to a point. Galleri says plainly that "No Cancer Signal Detected does not rule out cancer," and that it should be used in addition to routine screening. If you take it, you still need your colonoscopy, mammogram or cervical screen.
Biological age tests: what they measure and how reliable they are
What is being measured
Most consumer biological age tests are epigenetic clocks. They read DNA methylation, chemical tags on your DNA that shift with age, and feed the pattern into a formula trained on large groups of people.
They are sold direct. TruDiagnostic's TruAge test lists at $499 as of 2026.
Some clocks lean on ordinary blood work. A 2018 paper in Aging by Morgan Levine, Steve Horvath and colleagues built a "phenotypic age" from nine standard lab markers plus your age: albumin, creatinine, glucose, C-reactive protein, lymphocyte percent, mean cell volume, red cell distribution width, alkaline phosphatase and white blood cell count. They then trained an epigenetic clock, DNAm PhenoAge, to predict it, and the abstract reports it predicted all-cause mortality, cancers, healthspan, physical functioning and Alzheimer's disease better than earlier measures.
How reliable the number is for one person
At the population level these clocks track ageing and disease risk well. For one person on one day, the number wobbles.
A 2022 Yale-led study found that estimates from earlier clocks "can often differ by up to nine years" when the same blood sample is measured twice, according to Yale School of Medicine. First author Albert Higgins-Chen put it plainly: "We found epigenetic clocks that could say you are biologically 50 years old on one test," and 59 on the next. His team's fix, a statistical rebuild of the clocks, brought repeat measurements much closer together: he said that "for most tests, two measurements done at the same time will differ by less than a year."
The field still lacks a shared yardstick. At a 2026 panel reported by The Scientist, Horvath, who built one of the first clocks, said "what the field has not yet achieved is really what one would call reference standards." The magazine notes that almost all clocks behind commercial tests are trained on blood, and Horvath told it, "When you apply a blood-trained clock to saliva without correction, the errors can be substantial."
So what is a biological age result good for? It can be a fun snapshot, and a series of tests from the same company under the same conditions may show a trend. It is a poor basis for a medical decision, and a two-year drop after a new supplement could easily be lab noise.
The price list side by side
| Item | What the rich pay (as of 2026) | Evidence it helps you live longer | Copy-it version |
|---|
| Mayo Clinic Executive Health visit | Not published; Mayo says most of a visit is typically insurance-covered (FAQ) | Strong for the Task Force screenings inside it; weak for several extras | Annual check-up with your own doctor |
| Executive physical at a top hospital | $1,700 to $10,000 per package in 2019 (JAMA) | Mixed: some packages included tests the Task Force advises against | Ask which screenings are recommended for your age |
| Fountain Life full subscription | $21,500 a year, 2025 report (TechCrunch) | No published outcome trials for the membership | Track your own numbers yearly |
| Fountain Life testing only | $10,500, 2025 report (TechCrunch) | Same | Same |
| Human Longevity 100+ Concierge | $19,000 a year (Human Longevity) | No published outcome trials for the membership | A doctor you can reach |
| Galleri multi-cancer test | $949 (HealthDay) | Missed main trial goal; fewer stage IV cancers; no survival data yet | Keep up with standard cancer screening |
| Epigenetic biological age test | $499 for TruAge (TruDiagnostic) | Good for groups, noisy for individuals | Phenotypic age from routine labs |
Look at the third column. The rows with the strongest evidence are the cheapest to get.
What to skip, or at least question
Tests the Task Force advises against for people like you. The JAMA study found resting ECGs, stress tests and carotid ultrasounds in many premium packages despite grade D ratings for low-risk adults. A grade D means the harms, mostly false alarms and follow-up procedures, are judged to outweigh the benefits. If you are paying, ask why each test is on your list.
Treating a clear Galleri result as a clean bill of health. The test missed most cancers in PATHFINDER 2. It is designed as an add-on to routine screening.
Chasing your biological age number. A score that older clocks could move by up to nine years between two runs of the same blood should not drive what you eat, take or spend.
Buying imaging as reassurance. Whole-body scans find many harmless things that lead to more scans and sometimes biopsies. The Prenuvo post goes through those numbers.
Assuming more tests means more years. None of the memberships here has published a trial showing members live longer than similar people who see a good regular doctor.
This post is general information for adults. Scans, cancer blood tests and follow-up procedures carry real risks, including false positives, radiation from CT, anxiety and invasive biopsies. Talk to your doctor before adding any of them, and especially before acting on a result.
What is worth paying for
If you have money to spend on a full check, here is a sensible order.
First, the screenings with strong evidence. These are the core of every good executive physical: blood pressure, cholesterol, diabetes screening, colorectal, breast and cervical cancer screening at the right ages, and lung cancer screening if your doctor says your smoking history qualifies. In the US, HealthCare.gov says many preventive services are "generally" covered "at no cost to you when provided by an in-network medical provider," even before you meet your deductible. That is the same foundation the Mayo protocol is built on.
Second, doctor time. The thing executives rave about is an unhurried physician who reads everything and coordinates referrals. That is worth real money for some people, and it is cheaper to buy on its own through concierge or direct primary care than as part of a $20,000 membership.
Third, extras matched to your risk. A strong family history of heart disease or a particular cancer can justify tests a low-risk person should skip. That is a conversation for your doctor, using your history.
Last on the list are the products sold as the future: multi-cancer blood tests and biological age clocks. They may earn a higher place as the survival data arrives. Right now, buying both is a roughly $1,450 bet on tools that have yet to show they help you live longer.
What would you do with $20,000 a year if you spent it on health some other way? A gym membership, a trainer, better food and a few extra hours of sleep are covered in posts like Peter Attia's protocol, and the training evidence there is stronger than the evidence for any scan.
Who really pays for executive health
There is a quieter lesson in the Mayo FAQ. Most executives in that program are there because a company pays, or because insurance covers most of the bill. The perk follows the job title. Health care at the top of the market is often a benefit of income and position, which is one more reason building your income matters. If you are still deciding how much you need before perks like these make sense, start with how much money is enough, and if you want a second income stream to fund them, see the best side hustles for 2026.
The other lesson is about compounding. A $21,500 annual membership over 20 years is $430,000. Put a fraction of that into a low-cost fund, as the index investing guide explains, and you have a health budget that grows while you sleep. Which do you think buys more good years: the membership, or the money left in the market plus the free screenings?
Your own executive physical this week
You can build most of the useful part of an executive physical in a week, for little or nothing.
- Book your annual preventive visit. In network, it is usually $0. Ask your doctor one question: "Which screenings are recommended for my age and history?"
- Write down your family history. Which relatives had heart disease, cancer, diabetes or dementia, and at what age? This costs nothing and shapes every test choice.
- Ask for your lab results in full. If your doctor already orders a blood count, metabolic panel and CRP, those cover most of the inputs to Levine's phenotypic age. Keep a simple spreadsheet so you can compare year to year.
- Check what you are overdue for. Colonoscopy, mammogram, cervical screen, lung CT if you qualify. Getting the overdue grade A or B test done beats any extra test you are not due for.
- Skip the $949 and $499 tests for now unless your doctor has a specific reason, and revisit after the FDA decision and the NHS-Galleri survival data.
Which of those five have you already done? Finishing the list gets you most of what the rich are paying for.